Post Covid-19 Syndrome Clinical Features Of Anterior Segment Of The Eye
Published 2023 - 41st Congress of the ESCRS
Reference: PO0801 | Type: Free paper | DOI: 10.82333/7r2k-1g86
Authors: Shakhzodbek Abdullaev* 1 , Zebiniso Niyazova 2 , Dilbarhon Makhkamova 2 , Aybek Abdullaev 1 , Zulfiya Shamsutdinova 2 , Mehridin Aslonov 3
1ophthalmology,Andijan State Medical Institute,Andijan,Uzbekistan, 2ophthalmology,Republican Specialized scientific practical center of eye microsurgery,Tashkent,Uzbekistan, 3ophthalmology,Tashkent Medical Academy,Tashkent,Uzbekistan
Purpose
To study the features of the manifestations of diseases of the anterior segment of the eye in postcovid conditions
Setting
We examined 19 patients with ocular manifestation of postcovid syndrome, 10 women (53% patients ) and 9 men (47% patients). Patients are divided into groups according to various clinical manifestations : 10 patients with follicular conjunctivitis, 7 patients with viral conjunctivitis, 2 patients with hemorrhagic keratoconjunctivitis.
Methods
All patients with follicular conjunctivitis had eye redness, contamination of the eyes with hands was noted, the conjunctival swas positive for 5 days. At the same time, in elderly people with diabetes and hypertension, the onset was later, and prolongation of the disease was also noted. Conjunctivitis was resolved within 2 weeks, after the appointment of moisturizing drops and moxifloxacin. Keratoconjunctivitis occurred in patients with moderate respiratory symptoms, while redness, discharge, photophobia were noted in patients, symptoms passed after treatment with oral valacyclovir, ophthalmoferon (human interferon), moxifloxacin.
Results
Conjunctival and nasal smear remained positive until the patients fully recovered. Some patients were also prescribed local corticosteroids, and long-term use of GCS is also recommended in order to reduce the risk of immunomodulated keratoconjunctivitis. Hemorrhagic conjunctivitis was detected in 2 patients with severe COVID-19 infection, patients were referred to intensive care unit (ICU), where they were treated with systemic administration of azithromycin and topical use of moxifloxacin, as well as GCS. These patients underwent daily sanitation of conjunctiva and removal of pseudomembranes.
Conclusions
The prevalence of ophthalmic manifestations among COVID-19 patients ranges from 2-32%. The given complications certainly deteriorate the life quality of individuals with COVID-19 infection. Thus it is crucial for eye-care specialists to get familiarized with the data provided in fresh researches carried out worldwide as well as in the given literature review and to be able to recognize and address them with sophisticated knowledge